Peran Skrining SGOT dan SGPT sebagai Deteksi Dini Risiko Hepatotoksisitas pada Usia Produktif
DOI:
https://doi.org/10.47709/hcs.v3i1.6286Keywords:
SGPT, SGOT, Fungsi Hati, Deteksi Dini, Edukasi KesehatanAbstract
Disfungsi hati subklinis sering tidak terdeteksi tanpa pemeriksaan laboratorium, padahal berperan penting dalam proses awal hepatotoksisitas. Peningkatan enzim hati seperti SGOT dan SGPT dapat mengindikasikan kerusakan hepatoseluler yang memerlukan intervensi preventif. Kegiatan pengabdian masyarakat dilakukan di kawasan Danau Sunter melalui skrining fungsi hati dan edukasi kesehatan. Pemeriksaan biokimia SGOT dan SGPT dilakukan terhadap 49 individu dewasa produktif. Data dikumpulkan dan dianalisis secara deskriptif. Edukasi disampaikan secara langsung berbasis hasil pemeriksaan masing-masing peserta. Sebagian besar peserta memiliki kadar SGOT normal (83,67%), namun peningkatan SGPT ditemukan pada 38,78% individu. Rerata SGOT dan SGPT masing-masing sebesar 25 U/L dan 27,48 U/L. Tingginya proporsi peningkatan SGPT menunjukkan adanya risiko disfungsi hepatoseluler ringan yang dapat dicegah melalui edukasi dan perubahan gaya hidup. Skrining fungsi hati disertai edukasi berbasis hasil merupakan pendekatan efektif dalam promosi kesehatan hepatik. Hasil ini menunjukkan pentingnya skrining hepatik dalam upaya promotif yang terjangkau dan berbasis komunitas untuk deteksi dini gangguan hati.
References
Böhmová, A., Mikoška, M., Syslová, K., Šindelá?ová, D., H?íbek, P., Urbánek, P., & Setni?ka, V. (2024). Untargeted metabolomics of blood plasma samples of patients with hepatocellular carcinoma. Journal of Pharmaceutical and Biomedical Analysis, 248, 116263. https://doi.org/10.1016/j.jpba.2024.116263
Islam, M. S., Wei, P., Suzauddula, M., Nime, I., Feroz, F., Acharjee, M., & Pan, F. (2024). The interplay of factors in metabolic syndrome: understanding its roots and complexity. Molecular Medicine (Cambridge, Mass.), 30(1), 279. https://doi.org/10.1186/s10020-024-01019-y
Islam, S., Rahman, S., Haque, T., Sumon, A. H., Ahmed, A. M., & Ali, N. (2020). Prevalence of elevated liver enzymes and its association with type 2 diabetes: A cross-sectional study in Bangladeshi adults. Endocrinology, Diabetes & Metabolism, 3(2), e00116. https://doi.org/10.1002/edm2.116
Kwo, P. Y., Cohen, S. M., & Lim, J. K. (2017). ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. The American Journal of Gastroenterology, 112(1), 18–35. https://doi.org/10.1038/ajg.2016.517
Labenz, C., Arslanow, A., Nguyen-Tat, M., Nagel, M., Wörns, M.-A., Reichert, M. C., Heil, F. J., Mainz, D., Zimper, G., Römer, B., Binder, H., Farin-Glattacker, E., Fichtner, U., Graf, E., Stelzer, D., Van Ewijk, R., Ortner, J., Velthuis, L., Lammert, F., & Galle, P. R. (2022). Structured Early detection of Asymptomatic Liver Cirrhosis: Results of the population-based liver screening program SEAL. Journal of Hepatology, 77(3), 695–701. https://doi.org/10.1016/j.jhep.2022.04.009
Leite, N., Tadiotto, M. C., Corazza, P. R. P., de Menezes Junior, F. J., Carli, M. E. C., Milano-Gai, G. E., Lopes, W. A., Gaya, A. R., Brand, C., Mota, J., & Radominski, R. B. (2022). Responsiveness on metabolic syndrome criteria and hepatic parameters after 12 weeks and 24 weeks of multidisciplinary intervention in overweight adolescents. Journal of Endocrinological Investigation, 45(4), 741–752. https://doi.org/10.1007/s40618-021-01699-x
Li, J., Wu, T., Zhang, X., Du, Y., Wei, B., & Wang, J. (2022). Clinical application of liver diseases diagnosis using ultrahigh-sensitive liquid chromatography-mass spectrometry for sialic acids detection. Journal of Chromatography. A, 1666, 462837. https://doi.org/10.1016/j.chroma.2022.462837
Lim, U., Monroe, K. R., Buchthal, S., Fan, B., Cheng, I., Kristal, B. S., Lampe, J. W., Hullar, M. A., Franke, A. A., Stram, D. O., Wilkens, L. R., Shepherd, J., Ernst, T., & Le Marchand, L. (2019). Propensity for Intra-abdominal and Hepatic Adiposity Varies Among Ethnic Groups. Gastroenterology, 156(4), 966-975.e10. https://doi.org/10.1053/j.gastro.2018.11.021
Mager, D. R., MacDonald, K., Duke, R. L., Avedzi, H. M., Deehan, E. C., Yap, J., Siminoski, K., & Haqq, A. M. (2022). Comparison of Body Composition, Muscle Strength and Cardiometabolic Profile in Children with Prader-Willi Syndrome and Non-Alcoholic Fatty Liver Disease: A Pilot Study. International Journal of Molecular Sciences, 23(23). https://doi.org/10.3390/ijms232315115
Norman, G. J., Carlson, J. A., Patrick, K., Kolodziejczyk, J. K., Godino, J. G., Huang, J., & Thyfault, J. (2017). Sedentary Behavior and Cardiometabolic Health Associations in Obese 11-13-Year Olds. Childhood Obesity (Print), 13(5), 425–432. https://doi.org/10.1089/chi.2017.0048
Noroozi Karimabad, M., Khalili, P., Ayoobi, F., Esmaeili-Nadimi, A., La Vecchia, C., & Jamali, Z. (2022). Serum liver enzymes and diabetes from the Rafsanjan cohort study. BMC Endocrine Disorders, 22(1), 127. https://doi.org/10.1186/s12902-022-01042-2
O’Dowd, E. L., Merriel, S. W. D., Cheng, V. W. T., Khan, S., Howells, L. M., Gopal, D. P., Roundhill, E. A., Brennan, P. M., Crosbie, P. A. J., Neal, R. D., Brown, K., Crosbie, E. J., & Baldwin, D. R. (2023). Clinical trials in cancer screening, prevention and early diagnosis (SPED): a systematic mapping review. BMC Cancer, 23(1), 820. https://doi.org/10.1186/s12885-023-11300-8
Park, E.-O., Bae, E. J., Park, B.-H., & Chae, S.-W. (2020). The Associations between Liver Enzymes and Cardiovascular Risk Factors in Adults with Mild Dyslipidemia. Journal of Clinical Medicine, 9(4). https://doi.org/10.3390/jcm9041147
Rahman, S., Islam, S., Haque, T., Kathak, R. R., & Ali, N. (2020). Association between serum liver enzymes and hypertension: a cross-sectional study in Bangladeshi adults. BMC Cardiovascular Disorders, 20(1), 128. https://doi.org/10.1186/s12872-020-01411-6
Rosoff, D. B., Charlet, K., Jung, J., Lee, J., Muench, C., Luo, A., Longley, M., Mauro, K. L., & Lohoff, F. W. (2019). Association of High-Intensity Binge Drinking With Lipid and Liver Function Enzyme Levels. JAMA Network Open, 2(6), e195844. https://doi.org/10.1001/jamanetworkopen.2019.5844
Zorina, E. S., & Naryzhny, S. N. (2025). Biomarkers of hepatocellular carcinoma: status and prospects. Biomeditsinskaia Khimiia, 71(1), 7–18. https://doi.org/10.18097/PBMCR1543
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Welly Hartono Ruslim, Alexander Halim Santoso, Edwin Destra, Ayleen Nathalie Jap, Stanislas Kotska Marvel Mayello Teguh
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
